Jefferies Group’s Ionis Pharmaceuticals IONS Stock Holding History

Jefferies Group’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-20,000	Closed	-$1.62M	–	2684
2019 Q1	$1.62M	Buy	+20,000	New	+$1.29M	0.01%	1018
2017 Q1	–	Sell	-13,500	Closed	-$646K	–	2488
2016 Q4	$646K	Hold	13,500	–	–	﹤0.01%	1489
2016 Q3	$495K	Buy	+13,500	New	+$422K	﹤0.01%	1630
2016 Q1	–	Sell	-17,100	Closed	-$1.06M	–	2396
2015 Q4	$1.06M	Buy	17,100 +12,400	+264%	+$669K	0.01%	1152
2015 Q3	$190K	Buy	+4,700	New	+$243K	﹤0.01%	1943
2014 Q3	–	Sell	-15,700	Closed	-$541K	–	2266
2014 Q2	$541K	Hold	15,700	–	–	﹤0.01%	1198
2014 Q1	$678K	Buy	+15,700	New	+$761K	0.01%	1110

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Jefferies Group's IONS Position: Q3 2022 in Review

Jefferies Group opened a new position in Ionis Pharmaceuticals (IONS) in Q3 2022: 105,566 shares worth $4.67M. The stake represents 0.04% of the portfolio and ranks #360 among its holdings. This is a return to the name: Jefferies Group previously reported a position in IONS as recently as Q4 2021.

Jefferies Group first reported a position in IONS in Q2 2013 and has held it in 27 quarters since. 349 funds tracked by Wall St. Rank hold IONS as of Q3 2022.

Jefferies Group held 105,566 shares of Ionis Pharmaceuticals worth $4.67M as of Q3 2022.
Ionis Pharmaceuticals was a new Jefferies Group position in Q3 2022.
Ionis Pharmaceuticals made up 0.04% of Jefferies Group's portfolio in Q3 2022, its #360 holding.
Jefferies Group first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 27 quarters since.
349 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.